Pembrolizumab Use Supported in Advanced Melanoma

Use supported regardless of BRAF V600E/K mutation status, receipt of prior BRAFi with/without MEKi
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Journal, Source Type: news